Trichloroacetaldehyde-13C2 Hydrate is labelled Trichloroacetaldehyde Hydrate (T774055). Studies have shown that when used in pediatric sedation side effects such as hallucination, excessive sleep and seizures were observed. It is sometimes administered to patients being treated with cyclophosphamide and it is known to inhibit some aldehyde dehydrogenases. This compound is suitable for aldehyde dehydrogenase (ALDH). Molecular Formula: 13C2H3Cl3O2 Solubility: DMSO (Slightly) Molecular Weight: 167.39 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
167.39
Form:
Supplied as a white to off-white solid.
* VAT and and shipping costs not included. Errors and price changes excepted
